Dr. Charles Donald Albury Jr. is a Nashville, Tennessee based Oral and Maxillofacial Surgeon who is specialized in Oral and Maxillofacial Surgery. He may accept the Medicare-approved amount. Patients may be billed for more than the Medicare deductible and coinsurance. His current practice location is 1005 Dr Db Todd Blvd, Nashville. Patients can reach him at 615-327-6180.
Dr. Charles Donald Albury Jr. deals with the diagnosis, surgical and adjunctive treatment of diseases, injuries and defects involving both the functional and esthetic aspects of the hard and soft tissues of the oral and maxillofacial region.
Complete Profile:
Dr. Charles Donald Albury Jr. speciality, credentials, practice address, contact phone number and fax are as below.
Patients can directly walk in or can call on the below given phone number for appointment.
Name:
Dr. Charles Donald Albury Jr.
Specialization:
Oral and Maxillofacial Surgeon
Gender:
Male
Credentials:
D.M.D.
Accepts Medicare Assignment:
May Accept
Practice Address:
1005 Dr Db Todd Blvd, Nashville, Tennessee, 37208
Phone:
615-327-6180
Fax:
615-327-6508
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details are as mentioned below.
PAC ID:
0648444372
Enrollment ID:
I20111115000648
NPI Number:
1932101367
NPI Enumeration Date:
15 Aug, 2005
NPI Last Update On:
24 Oct, 2013
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
7533 Oak Haven Trce, Nashville, Tennessee
Zip:
37209-3500
Phone Number:
615-948-3096
Fax Number:
615-356-2134
Patients can reach Dr. Charles Donald Albury Jr. at 1005 Dr Db Todd Blvd, Nashville, Tennessee or can call to book an appointment on 615-327-6180. Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 11 November, 2024.